Gestational phthalate exposure and lung function during childhood: A prospective population-based study.


Journal

Environmental pollution (Barking, Essex : 1987)
ISSN: 1873-6424
Titre abrégé: Environ Pollut
Pays: England
ID NLM: 8804476

Informations de publication

Date de publication:
01 Nov 2022
Historique:
received: 31 01 2022
revised: 19 07 2022
accepted: 20 07 2022
pubmed: 6 8 2022
medline: 28 9 2022
entrez: 5 8 2022
Statut: ppublish

Résumé

The potential effect of gestational exposure to phthalates on the lung function levels during childhood is unclear. Therefore, we examined this association at different ages (from 4 to 11 years) and over the whole childhood. Specifically, we measured 9 phthalate metabolites (MEP, MiBP, MnBP, MCMHP, MBzP, MEHHP, MEOHP, MECPP, MEHP) in the urine of 641 gestating women from the INMA study (Spain) and the forced vital capacity (FVC), forced expiratory volume in 1 s (FEV

Identifiants

pubmed: 35931390
pii: S0269-7491(22)01047-8
doi: 10.1016/j.envpol.2022.119833
pii:
doi:

Substances chimiques

Environmental Pollutants 0
Phthalic Acids 0
phthalic acid 6O7F7IX66E

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

119833

Informations de copyright

Copyright © 2022 The Authors. Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Judith Garcia-Aymerich reports a relationship with AstraZeneca Pharmaceuticals LP that includes: consulting or advisory and speaking and lecture fees. Judith Garcia-Aymerich reports a relationship with Esteve Quimica SA that includes: speaking and lecture fees. Judith Garcia-Aymerich reports a relationship with Chiesi Pharmaceuticals Inc that includes: speaking and lecture fees.

Auteurs

Magda Bosch de Basea (M)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain. Electronic address: magda.boschdebasea@isglobal.org.

Anne-Elie Carsin (AE)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain.

Alicia Abellan (A)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona. Spain.

Inés Cobo (I)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Aitana Lertxundi (A)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; BIODONOSTIA Health Research Institute, Environmental Epidemiology and Child Development Group, San Sebastian, Spain; Faculty of Medicine and Nursery of the University of the Basque Country (UPV-EHU), Leioa, Spain.

Natalia Marin (N)

Epidemiology and Environmental Health Joint Research Unit, FISABIO -Universitat Jaume I - Universitat de València, Valencia, Spain.

Raquel Soler-Blasco (R)

Epidemiology and Environmental Health Joint Research Unit, FISABIO -Universitat Jaume I - Universitat de València, Valencia, Spain.

Jesús Ibarluzea (J)

CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; BIODONOSTIA Health Research Institute, Environmental Epidemiology and Child Development Group, San Sebastian, Spain; Ministry of Health of the Basque Government, Sub-Directorate for Public Health and Addictions of Gipuzkoa, San Sebastian, Spain; Faculty of Psychology of the University of the Basque Country (UPV-EHU), San Sebastian, Spain.

Martine Vrijheid (M)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Jordi Sunyer (J)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain; IMIM, Hospital del Mar Medical Research Institute, Barcelona, Spain.

Maribel Casas (M)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Judith Garcia-Aymerich (J)

Barcelona Institute for Global Health (ISGlobal), Barcelona, Catalonia, Spain; Universitat Pompeu Fabra (UPF), Barcelona, Spain; CIBER Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH